article thumbnail

AI-powered tool may offer quick, no-contact blood pressure and diabetes screening

American Heart News - Heart News

Research Highlights: A preliminary study combining a patent-applied, AI-powered algorithm with a high-speed, 5-to 30-second video of skin on the face and the palm of the hand detected if someone had high blood pressure as well as using a blood.

article thumbnail

Intensive Blood Pressure Control Benefits People With Type 2 Diabetes Too

Med Page Today

(MedPage Today) -- CHICAGO -- The cardiovascular outcome benefit of a tighter systolic blood pressure target was affirmed in patients with type 2 diabetes in the randomized BPROAD trial from China. A target of less than 120 mm Hg reduced a composite.

article thumbnail

Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

The New England Journal of Medicine

In this trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-pressure target of less than 120 mm Hg than with a target of less than 140 mm Hg.

article thumbnail

Childhood stress linked to higher risk of high blood pressure, obesity, diabetes in adults

Science Daily - Heart Disease

Young adults who reported higher stress as adolescents were more likely to have high blood pressure, obesity and other cardiometabolic risk factors as adults, finds new study.

article thumbnail

Lower blood pressure for diabetic patients can reduce cardiovascular disease

Medical Xpress - Cardiology

People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular disease when their blood pressure was lower than the current standard goal, a UT Southwestern Medical Center researcher and his colleagues found.

article thumbnail

New Study Finds Tirzepatide Use Lowered Blood Pressure in Patients with Obesity

HCPLive

Tirzepatide, a dual GLP-1/GIP agonist approved for diabetes and obesity, was associated with significant blood pressure reductions in an analysis of the SURMOUNT-1 trial.

article thumbnail

One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

DAIC

Akshay Desai, MD “Compared to placebo, a single injection of zilebesiran resulted in clinically meaningful reductions in blood pressure at three months when added to commonly used antihypertensive treatments,” said Akshay Desai, MD, MPH , a cardiologist at Brigham and Women’s Hospital in Boston and a study coauthor. “In